Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis

CONCLUSIONS: These antibodies label aged, non-native TTR deposits, leaving native TTR unattended and thereby potentially enabling new therapeutic …